SCHEMBL7620201

SCHEMBL7620201

CN[C@@H]1c2ccccc2CN2CCCC[C@@H]12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.44
SLC18A3 Q16572 1/20 0.42
CHRNA7 P36544 1/20 0.41
OPRM1 P35372 2/20 0.39
OPRK1 P41145 2/20 0.39
ADRA2B P18089 2/20 0.38
ADRA2C P18825 2/20 0.38
SLC6A2 P23975 2/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
SLC6A4 P31645 2/20 0.38
HRH1 P35367 2/20 0.38
HTR2B P41595 2/20 0.38
KCNH2 Q12809 2/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
SLC6A3 Q01959 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7620196 1.00 PDPK1 (0.44) PDPK1SLC18A3CHRNA7OPRM1OPRK1
SCHEMBL7620191 1.00 PDPK1 (0.44) PDPK1SLC18A3CHRNA7OPRM1OPRK1
SCHEMBL7617561 0.95 CHRNA7 (0.45) PDPK1SLC18A3CHRNA7OPRM1OPRK1
SCHEMBL7617549 0.95 CHRNA7 (0.45) PDPK1SLC18A3CHRNA7OPRM1OPRK1
SCHEMBL7626235 0.95 CHRNA7 (0.45) PDPK1SLC18A3CHRNA7OPRM1OPRK1
SCHEMBL7617553 0.95 CHRNA7 (0.45) PDPK1SLC18A3CHRNA7OPRM1OPRK1
SCHEMBL9748978 0.86 PDPK1 (0.54) PDPK1CHRNA7OPRM1OPRK1
SCHEMBL14367944 0.86 PDPK1 (0.50) PDPK1CHRNA7
SCHEMBL4863623 0.86 PDPK1 (0.54) PDPK1CHRNA7OPRM1OPRK1
SCHEMBL4863616 0.86 PDPK1 (0.54) PDPK1CHRNA7OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436954-B1 BENZO(B)QUINOLIZIDINE AND BENZO(F)INDOLIZIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF ALZHEIMER'S DISEASE, SENILE DEMENTIA OR OTHER CONDITIONS CHARACTERIZED BY MEMORY LOSS; PYRROLO(1,2-B)ISOQUINOLINES, BENZO(B)QUINOLIZINES AMERICAN BIOGENETIC SCIENCES, INC. 2002-08-20 US disclosed